| Date |
Report No. |
Title |
| Date Nov. 13, 2006 |
Report No. GAO-07-77 |
Title
United States Government Accountability Office GAO
November 2006 Report to the Chairman, Committee on Ways and Means, House of Representatives END-STAGE RENAL DISEASE Bundling Medicare’s Payment for Drugs with Payment for All ESRD Services Would Promote Efficiency and Clinical Flexibility GAO-07-77 November 2006 END-STAGE RENAL DISEASE Highlights
Highlights of GAO-07-77, a report to the Chairman... |
| Date July 13, 2006 |
Report No. GAO-06-971T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 1:00 p.m. EDT Thursday, July 13, 2006 Testimony Before the Subcommittee on Health, Committee on Ways and Means, House of Representatives MEDICARE PART B DRUGS CMS Data Source for Setting Payments Is Practical but Concerns Remain
Statement of A. Bruce Steinwald Director, Health Care GAO-06-971T July 13, 2006 MEDI... |
| Date June 30, 2006 |
Report No. GAO-06-710 |
Title
United States Government Accountability Office GAO
June 2006 Report to Congressional Requesters MEDICARE PART D Prescription Drug Plan Sponsor Call Center Responses Were Prompt, but Not Consistently Accurate and Complete GAO-06-710 June 2006 MEDICARE PART D Highlights
Highlights of GAO-06-710, a report to congressional requesters Accountability Integrity Reliability Prescription Drug Plan Sponsor ... |
| Date May 4, 2006 |
Report No. GAO-06-715T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:00 p.m. EDT Thursday, May 4, 2006 Testimony Before the Subcommittee on Health, Committee on Ways and Means, House of Representatives MEDICARE Quality of CMS Communications to Beneficiaries on the Prescription Drug Benefit Could Be Improved
Statement of Leslie G. Aronovitz Director, Health Care GAO-06-715T May ... |
| Date May 3, 2006 |
Report No. GAO-06-654 |
Title
United States Government Accountability Office GAO
May 2006 Report to Congressional Requesters MEDICARE Communications to Beneficiaries on the Prescription Drug Benefit Could Be Improved GAO-06-654 May 2006 MEDICARE Highlights
Highlights of GAO-06-654, a report to congressional requesters Accountability Integrity Reliability Communications to Beneficiaries on the Prescription Drug Benefit Could Be... |
| Date April 28, 2006 |
Report No. GAO-06-372 |
Title
United States Government Accountability Office GAO
April 2006 Report to Congressional Committees MEDICARE HOSPITAL PHARMACEUTICALS Survey Shows Price Variation and Highlights Data Collection Lessons and Outpatient Rate-Setting Challenges for CMS GAO-06-372 April 2006 Highlights
Highlights of GAO-06-372, a report to congressional committees Accountability Integrity Reliability MEDICARE HOSPITAL PHA... |
| Date April 26, 2006 |
Report No. GAO-06-681T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:30 p.m. EDT Wednesday, April 26, 2006 Testimony Before the Subcommittee on Federal Financial Management, Government Information, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate RYAN WHITE CARE ACT AIDS Drug Assistance Programs, Perinatal HIV Transmission, and Pa... |
| Date April 26, 2006 |
Report No. GAO-06-646 |
Title
United States Government Accountability Office GAO
April 2006 Report to Congressional Requesters RYAN WHITE CARE ACT Improved Oversight Needed to Ensure AIDS Drug Assistance Programs Obtain Best Prices for Drugs GAO-06-646 April 2006 RYAN WHITE CARE ACT Highlights
Highlights of GAO-06-646, a report to congressional requesters Accountability Integrity Reliability Improved Oversight Needed to Ensure... |
| Date March 31, 2006 |
Report No. GAO-06-402 |
Title
United States Government Accountability Office GAO
March 2006 Report to Congressional Requesters DRUG SAFETY Improvement Needed in FDA’s Postmarket Decision-making and Oversight Process GAO-06-402 March 2006 DRUG SAFETY Highlights
Highlights of GAO-06-402, a report to the Chairman, Committee on Finance, United States Senate and the Chairman, Committee on Energy and Commerce, House of Representat... |
| Date Jan. 13, 2006 |
Report No. GAO-06-299R |
Title
United States Government Accountability Office Washington, DC 20548 January 13, 2006 The Honorable Henry A. Waxman Ranking Minority Member Committee on Government Reform House of Representatives Subject: Medicare: Sponsors’ Management of the Prescription Drug Discount Card and Transitional Assistance Benefit Dear Mr. Waxman: The Medicare Prescription Drug, Improvement, and Modernization Act of 2... |
| Date Dec. 16, 2005 |
Report No. GAO-06-278R |
Title
United States Government Accountability Office Washington, DC 20548 December 16, 2005 The Honorable Max Baucus Ranking Minority Member Committee on Finance United States Senate Subject: Medicare: Contingency Plans to Address Potential Problems with the Transition of Dual-Eligible Beneficiaries from Medicaid to Medicare Drug Coverage Dear Senator Baucus: The Medicare Prescription Drug, Improvement,... |
| Date Dec. 13, 2005 |
Report No. GAO-06-175T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 1:00 p.m. EST Tuesday, December 13, 2005 Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives PRESCRIPTION DRUGS Enhanced Efforts and Better Agency Coordination Needed to Address Illegal Importation
Statement of Richard M. Stana, Direc... |
| Date Oct. 31, 2005 |
Report No. GAO-06-78R |
Title
United States Government Accountability Office Washington, DC 20548 October 28, 2005 The Honorable Henry A. Waxman Ranking Minority Member Committee on Government Reform House of Representatives Subject: Medicare: CMS’s Implementation and Oversight of the Medicare Prescription Drug Discount Card and Transitional Assistance Program Dear Mr. Waxman: The Medicare Prescription Drug, Improvement and ... |
| Date Oct. 31, 2005 |
Report No. GAO-06-69R |
Title
United States Government Accountability Office Washington, DC 20548 October 31, 2005 The Honorable Edward Whitfield Chairman Subcommittee on Oversight and Investigations Committee on Energy and Commerce House of Representatives Subject: Medicaid: States’ Payments for Outpatient Prescription Drugs Dear Mr. Chairman: Spending on outpatient prescription drug coverage for Medicaid beneficiaries has ... |
| Date Sept. 8, 2005 |
Report No. GAO-05-372 |
Title
United States Government Accountability Office GAO
September 2005 Report to Congressional Requesters PRESCRIPTION DRUGS Strategic Framework Would Promote Accountability and Enhance Efforts to Enforce the Prohibitions on Personal Importation GAO-05-372 September 2005 PRESCRIPTION DRUGS Highlights
Highlights of GAO-05-372, a report to congressional requesters Accountability Integrity Reliability Str... |
| Date Aug. 15, 2005 |
Report No. GAO-05-779 |
Title
United States Government Accountability Office GAO
August 2005 Report to Congressional Requesters PRESCRIPTION DRUGS Price Trends for Frequently Used Brand and Generic Drugs from 2000 through 2004 GAO-05-779 August 2005 PRESCRIPTION DRUGS Highlights
Highlights of GAO-05-779, a report to congressional requesters Accountability Integrity Reliability Price Trends for Frequently Used Brand and Generic... |
| Date Feb. 14, 2005 |
Report No. GAO-05-205 |
Title
United States Government Accountability Office GAO
February 2005 Report to Congressional Committees RETIREE HEALTH BENEFITS Options for Employment-Based Prescription Drug Benefits under the Medicare Modernization Act GAO-05-205 February 2005 RETIREE HEALTH BENEFITS Highlights
Highlights of GAO-05-205, a report to congressional committees Accountability Integrity Reliability Options for Employment-... |
| Date Oct. 6, 2004 |
Report No. GAO-05-104R |
Title
United States Government Accountability Office Washington, DC 20548 October 6, 2004 The Honorable Olympia J. Snowe Chair Committee on Small Business and Entrepreneurship United States Senate The Honorable Ron Wyden Ranking Minority Member Subcommittee on Consumer Affairs and Product Safety Committee on Commerce, Science, and Transportation United States Senate Subject: Prescription Drugs: Trends i... |
| Date July 22, 2004 |
Report No. GAO-04-839T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:00 a.m. EDT Thursday, July 22, 2004 Testimony Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate PRESCRIPTION DRUGS Preliminary Observations on Efforts to Enforce the Prohibitions on Personal Importation
Statement of Richard M. Stana, Director Homeland Security ... |
| Date June 17, 2004 |
Report No. GAO-04-888T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:00 a.m. EDT Thursday, June 17, 2004 Testimony Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate INTERNET PHARMACIES Some Pose Safety Risks for Consumers and Are Unreliable in Their Business Practices
Statement of Marcia Crosse Director, Health Care—Public Health and... |
| Date March 4, 2004 |
Report No. GAO-04-524T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m. EST Thursday, March 4, 2004 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives PRESCRIPTION DRUGS State Monitoring Programs May Help to Reduce Illegal Diversion
Statement of Marcia Crosse Director, Health Care—Public Health and Military Health Care Issues... |
| Date Dec. 19, 2003 |
Report No. GAO-04-110 |
Title
United States General Accounting Office GAO
December 2003 Report to Congressional Requesters PRESCRIPTION DRUGS OxyContin Abuse and Diversion and Efforts to Address the Problem GAO-04-110 December 2003 PRESCRIPTION DRUGS OxyContin Abuse and Diversion and Efforts to Address the Problem Highlights of GAO-04-110, a report to congressional requesters Amid heightened awareness that many patients with c... |
| Date Oct. 23, 2003 |
Report No. GAO-04-195T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Thursday, October 23, 2003 Testimony Before the Committee on Health, Education, Labor, and Pensions, U.S. Senate PRESCRIPTION DRUGS State and Federal Oversight of Drug Compounding by Pharmacies
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-04-195T October 23, 2003 PRESCRIPTION ... |
| Date Sept. 3, 2003 |
Report No. GAO-03-912 |
Title
United States General Accounting Office GAO
September 2003 Report to Congressional Requesters PRESCRIPTION DRUG DISCOUNT CARDS Savings Depend on Pharmacy and Type of Card Used GAO-03-912 September 2003 PRESCRIPTION DRUG DISCOUNT CARDS
Highlights of GAO-03-912, a report to congressional requesters Savings Depend on Pharmacy and Type of Card Used While prescription drugs have become an increasingly ... |
| Date Oct. 28, 2002 |
Report No. GAO-03-177 |
Title
United States General Accounting Office GAO
October 2002 Report to Congressional Requesters PRESCRIPTION DRUGS FDA Oversight of Direct-to-Consumer Advertising Has Limitations GAO-03-177 Contents Letter
Results in Brief Background Pharmaceutical Companies Spend More on Research and Development than on DTC Advertising DTC Advertising Appears to Increase Prescription Drug Spending and Utilization FDA... |
| Date May 17, 2002 |
Report No. GAO-02-634 |
Title
United States General Accounting Office GAO
May 2002 Report to the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives PRESCRIPTION DRUGS State Monitoring Programs Provide Useful Tool to Reduce Diversion GAO-02-634 Contents Letter
Results in Brief Background PDMPs Vary in Objectives, Design, and Operation State Programs Have Helped Shorten Inves... |
| Date Dec. 5, 2001 |
Report No. GAO-02-280R |
Title
United States General Accounting Office Washington, DC 20548 December 5, 2001 Congressional Requesters Subject: Prescription Drugs: Prices Available Through Discount Cards and From Other Sources This letter responds to your request for information on how the prices for prescription drugs purchased using drug discount cards compare with the prices available at local pharmacies or over the Internet.... |
| Date Sept. 21, 2001 |
Report No. GAO-01-1142T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Health and the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives For Release on Delivery Expected at 9:30 a.m. Friday, September 21, 2001 MEDICARE PART B DRUGS Program Payments Should Reflect Market Prices
Statement of William J. Scanlon Director, Health Care Issu... |
| Date Jan. 29, 2001 |
Report No. GAO-01-183 |
Title
United States General Accounting Office GAO
January 2001 Report to the Ranking Member, Committee on Veterans’ Affairs, U.S. Senate VA DRUG FORMULARY Better Oversight Is Required, but Veterans Are Getting Needed Drugs GAO-01-183 Letter Appendixes
Appendix I: Scope and Methodology 3 24 29 33 34 Table 1: Percentage of Total Outpatient Prescriptions Filled for National Formulary Drugs by VISN and Me... |
| Date Nov. 16, 2000 |
Report No. GAO-01-137 |
Title
United States General Accounting Office GAO
November 2000 Report to Congressional Requesters PRESCRIPTION DRUGS Drug Company Programs Help Some People Who Lack Coverage GAO-01-137 Contents Letter Appendix Tables
Appendix I: Scope and Methodology 3 16 Table 1: Reported Annual Income Limits for Eligibility in Patient Assistance Programs, 1998 Table 2: Programs Offering and Requiring Applications for... |
| Date Aug. 10, 2000 |
Report No. HEHS-00-140 |
Title
United States General Accounting Office GAO
August 2000 Report to Congressional Requesters PRESCRIPTION DRUGS Many Factors Affected FDA’s Approval of Selected “Pipeline” Drugs GAO/HEHS-00-140 Contents Letter Appendixes
Appendix I: Scope and Methodology 3 26 29 32 45 49 Appendix II: Approval Time Comparisons Appendix III: Approval Process for Claritin Appendix IV: Approval Process for Relafen... |
| Date Aug. 7, 2000 |
Report No. HEHS-00-118 |
Title
United States General Accounting Office GAO
August 2000 Report to Congressional Requesters PRESCRIPTION DRUGS Expanding Access to Federal Prices Could Cause Other Price Changes GAO/HEHS-00-118 Contents Letter Tables
Table 1: Pharmaceutical Pricing Terms Table 2: Prices for Select Prescription Drugs Commonly Used by the Elderly, February 2000 3 9 12 Abbreviations AMP AWP CBO DOD FCP FSS GSA HCFA HM... |
| Date May 11, 2000 |
Report No. T-HEHS-00-112 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. Thursday, May 11, 2000 Testimony
Before the Subcommittee on Health, Committee on Ways and Means, House of Representatives PRESCRIPTION DRUGS Adapting Private Sector Management Methods for a Medicare Benefit
Statement of William J. Scanlon, Director Health Financing and Public Health Issues Health, Education, ... |
| Date March 22, 2000 |
Report No. T-HEHS-00-84 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, March 22, 2000 Testimony
Before the Committee on Finance, U.S. Senate PRESCRIPTION DRUG BENEFITS Applying Private Sector Management Methods to Medicare
Statement of William J. Scanlon, Director Health Financing and Public Health Issues Health, Education, and Human Services Division GAO/T-HEHS-00-8... |
| Date March 1, 2000 |
Report No. HEHS-00-70R |
Title
- A
Accountability * Integrity * Reliability eGA0
United States General Accounting Washington, DC 20548 Office Health, Education, aud Human Services Division B-i.!84796 March 1,ZOOO The Honorable John D. Dingell Ranking Minority Member Committee on Commerce House of Representatives Subject: Mediaap: Premiums Dear Mr. Dingell: This letter is in response to your request for information on premiums f... |
| Date Feb. 16, 2000 |
Report No. T-HEHS/AIMD-00-100 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, February 16, 2000 Testimony
Before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives PRESCRIPTION DRUGS Increasing Medicare Beneficiary Access and Related Implications
Statement of William J. Scanlon, Director Health Financing and Public Health Issues Heal... |
| Date Feb. 15, 2000 |
Report No. T-HEHS/AIMD-00-99 |
Title
United States General Accounting Office Testimony
Before the Subcommittee on Health, Committee on Ways and Means, House of Representatives Tuesday, February 15, 2000 PRESCRIPTION DRUGS Increasing Medicare Beneficiary Access and Related Implications
Statement of David M. Walker Comptroller General of the United States GA O
GAO/T-HEHS/AIMD-00-99 Mr. Chairman and Members of the Subcommittee: I am ple... |
| Date Feb. 1, 2000 |
Report No. T-HEHS-00-53 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Tuesday, Feb. 1, 2000 Testimony
Before the Committee on Health, Education, Labor, and Pensions, U.S. Senate ADVERSE DRUG EVENTS Substantial Problem but Magnitude Uncertain
Statement of Janet Heinrich, Associate Director Health Financing and Public Health Issues Health and Human Services Division GAO/T-HEHS-0... |
| Date Jan. 18, 2000 |
Report No. HEHS-00-21 |
Title
United States General Accounting Office GAO
January 2000 Report to Congressional Requesters ADVERSE DRUG EVENTS The Magnitude of Health Risk Is Uncertain Because of Limited Incidence Data GAO/HEHS-00-21 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-281822 January 18, 2000 Congressional Requesters In 1998, about 2.7 billion presc... |
| Date Sept. 28, 1999 |
Report No. T-HEHS-99-198 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Tuesday, September 28, 1999 Testimony
Before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives MEDICARE Beneficiaries’ Prescription Drug Coverage
Statement of Laura A. Dummit, Associate Director Health Financing and Public Health Issues Health, Education, and Human... |
| Date June 23, 1999 |
Report No. T-HEHS-99-153 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, June 23, 1999 Testimony
Before the Committee on Finance, U.S. Senate MEDICARE Considerations for Adding a Prescription Drug Benefit
Statement of Laura A. Dummit, Associate Director Health Financing and Public Health Issues Health, Education, and Human Services Division GAO/T-HEHS-99-153 Medicare: ... |
| Date June 8, 1999 |
Report No. HEHS-99-134R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-282860 June 8, 1999 The Honorable Don Nickles United States Senate Subject: Defense Health Care: Pharmacy Copavments Dear Senator Nickles: This responds to your March 17, 1999, referral to us of a letter that several constituents sent you regarding our recent report and testimony on ... |
| Date March 17, 1998 |
Report No. HEHS-98-21 |
Title
United States General Accounting Office GAO
March 1998 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives FOOD AND DRUG ADMINISTRATION Improvements Needed in the Foreign Drug Inspection Program GAO/HEHS-98-21 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-275814 M... |
| Date Sept. 19, 1996 |
Report No. T-HEHS-96-216 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Thursday, September 19, 1996 Testimony
Before the Subcommittee on Oversight and Investigations Committee on Commerce, House of Representatives PRESCRIPTION DRUG PRICING Implications for Retail Pharmacies
Statement of Sarah F. Jaggar, Director Health Services Quality and Public Health Health, Education, and H... |
| Date Sept. 12, 1996 |
Report No. T-HEHS-96-212 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. September 12, 1996 Testimony
Before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U. S. House of Representatives PRESCRIPTION DRUGS Implications of Drug Labeling and Off-Label Use
Statement of Sarah F. Jagger Director of Health Services Qua... |
| Date June 11, 1996 |
Report No. AIMD-96-72 |
Title
United States General Accounting Office GAO
June 1996 Report to Congressional Requesters PRESCRIPTION DRUGS AND MEDICAID Automated Review Systems Can Help Promote Safety, Save Money G A O years
1921 - 1996 GAO/AIMD-96-72 GAO United States General Accounting Office Washington, D.C. 20548 Accounting and Information Management Division B-261530 June 11, 1996 The Honorable William F. Clinger, Jr. Chai... |
| Date March 28, 1996 |
Report No. T-HEHS-96-114 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m. Thursday, March 28, 1996 Testimony
Before the Special Committee on Aging, U.S. Senate PRESCRIPTION DRUGS AND THE ELDERLY Many Still Receive Potentially Harmful Drugs Despite Recent Improvements
Statement of Sarah F. Jaggar, Director Health Financing and Public Health Issues Health, Education, and Human Servic... |
| Date July 24, 1995 |
Report No. HEHS-95-152 |
Title
United States General Accounting Office GAO
July 1995 Report to the Honorable Ron Wyden, House of Representatives PRESCRIPTION DRUGS AND THE ELDERLY Many Still Receive Potentially Harmful Drugs Despite Recent Improvements GAO/HEHS-95-152 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-259603 July 24, 1995 The Honorable Ron Wyden H... |
| Date April 28, 1995 |
Report No. HEHS-95-90 |
Title
United States General Accounting Office 3AO Report to the Chairman, Special Committee on Aging, U.S. Senate Apil 1995 PRESCRIPTION DRUG
PRICES Official Index Overstates Producer Price Inflation GAO/IEHS-95-90 GAO ~~~~~~Washington,D.C. 20548 United States General Accounting Office Health, Education, and Human Services Division B-260293 April 28, 1995 The Honorable William S. Cohen Chairman, Special... |
| Date Oct. 24, 1994 |
Report No. HEHS-95-13 |
Title
United States General Accounting Office GAO
October 1994 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives VETERANS' HEALTH CARE Use of VA Services by Medicare-Eligible Veterans GAO/HEHS-95-13 United States GAO Washington, D.C. 20548
Health, Education, and Human Services Division B-256395 October 24, 1994 The Honorable La... |
